Euskara
|
Español
|
English
Identifikatu
Taldeak
Ikertzaileak
Emaitzak
JOSE ANTONIO
IRIBARREN LOYARTE
IRAKASLE AGREGATUA
University of Texas Southwestern Medical Center
Dallas, Estados Unidos
Hemen zaude
Lankidetzak
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
Irisgarritasuna
|
Lege oharra
|
Kontaktua
|
Mapa
|
Laguntza
UPV/EHU